Hedia Diabetes Assistant, a tailored solution aiming to answer the needs of people with diabetes. Our company's software is a digital diabetes assistant that aims to help people living with diabetes (MDI-regimen) better manage their disease. ​MDI market represents a serious problem as 75% of all people with Type 1 Diabetes are not meeting their glycemic targets and 20% are in very poorly glycemic control, which drastically increases the risks and comorbidities related to diabetes. These numbers translate to about 110 million MDI patients globally, who need a solution that feeds seamlessly into their lives and offers ease of mind while improving their health.​

Hedia is a digital therapeutic company, with a product (SaMD, class IIb in EU) for insulin requiring diabetes patients.​ Hedia’s app solution generates insulin recommendations, based on the users' habits and personalized input.​ The app takes all aspects of diabetes management into account such as: recording blood glucose readings, keeping track of active insulin, measuring carbs, calculating an insulin dosage, keeping track of activity and recording blood ketones.​ Hedia is striving to improve patient’s health and reduce long-term effects of the disease, which we believe in the end then will reduce costs incurred by the healthcare payer.​

Evidence 1:​ First of all, the features within the app are built on research that already exists. 

Evidence 2: Furthermore, because our product is CE-marked as class IIB, it is both a part of our mindset as a company and an actual requirement to be able to document the safety and performance of our product at all times. ​

Evidence 3: We also have our retrospective study which showed us that:​

• Poorly regulated users of HDA experience significant improvements after 12 weeks of using the app. ​
• A decrease of 0.78 % of estimated A1C was detected in the group of more poorly controlled users ​
• And the users increased their estimated time-in-range with 12,35 -points% over the 12 weeks